Cadmium disrupts the DNA damage response by destabilizing RNF168

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Shuyuan ZhangHailong Wang

Abstract

Cadmium (Cd) is a dispensable element for the human body and is usually considered a carcinogen. Occupational and environmental Cd exposure leads to sustained cellular proliferation in some tissues and tumorigenesis via an unclear mechanism. Here, we evaluated the role of Cd in the DNA damage response (DDR). We found that Cd exposure causes extensive DNA double-strand breaks (DSBs) and prevents accumulation of ubiquitination signals at these sites of DNA damage. Cd treatment compromises 53BP1 and BRCA1 recruitment to DSBs induced by itself or DNA damaging agents and partially inactivates the G2/M checkpoint. Mechanistically, Cd directly binds to the E3 ubiquitin ligase RNF168, induces the ubiquitin-proteasome pathway that mediates RNF168 degradation and suppresses RNF168 ubiquitin-ligase activity in vitro. Our study raises the possibility that Cd may target RNF168 to disrupt proper DSB signaling in cultured cells. This pathway may represent a novel mechanism for carcinogenesis induced by Cd.

References

Jan 1, 1992·Critical Reviews in Toxicology·M P WaalkesR A Barter
Jan 1, 1988·Progress in Nucleic Acid Research and Molecular Biology·J F Ward
Apr 24, 1997·Nature·K W Kinzler, B Vogelstein
Nov 5, 1999·Molecular Cell·M E MoynahanM Jasin
Mar 10, 2001·Nature Genetics·K K Khanna, S P Jackson
Jun 8, 2001·Annual Review of Biochemistry·C M Pickart
Feb 8, 2002·Cell·Ashok R Venkitaraman
May 4, 2002·Nature Reviews. Molecular Cell Biology·Damien D'Amours, Stephen P Jackson
Dec 25, 2002·The Journal of Biological Chemistry·Xingzhi Xu, David F Stern
Feb 28, 2003·Nature·Michal GoldbergStephen P Jackson
Feb 28, 2003·Nature·Grant S StewartStephen J Elledge
Oct 2, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xingzhi Xu, David F Stern
Oct 29, 2003·Toxicology·Michael WaisbergDetmar Beyersmann
Jul 29, 2004·DNA Repair·Craig H Bassing, Frederick W Alt
Dec 2, 2004·Biochimica Et Biophysica Acta·Cecile M Pickart, Michael J Eddins
Aug 17, 2005·Cell Cycle·Stephen T Durant, Jac A Nickoloff
Sep 21, 2005·Cancer Letters·Da-Tian BauChen-Yang Shen
Nov 30, 2005·Mutagenesis·Hiroyuki Niida, Makoto Nakanishi
Oct 19, 2007·Nature Reviews. Cancer·Markus Löbrich, Penny A Jeggo
May 28, 2008·The Journal of Cell Biology·Katherine Minter-DykhouseZhenkun Lou
Feb 25, 2009·Toxicology and Applied Pharmacology·Jie LiuMaria B Kadiiska
Apr 18, 2009·Toxicology and Applied Pharmacology·Pius Joseph
Oct 23, 2009·Nature·Stephen P Jackson, Jiri Bartek
Oct 31, 2009·Trends in Biochemical Sciences·Michael S Y Huen, Junjie Chen
Nov 3, 2010·Advances in Cancer Research·Joanne SmithDavid A Gillespie
Oct 27, 2011·Seminars in Cell & Developmental Biology·Torben R Kasparek, Timothy C Humphrey

❮ Previous
Next ❯

Citations

Dec 8, 2020·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Jessalyn L IerardiAnnalaura Mancia
Aug 24, 2021·Journal of Toxicology·Suryakant NitureDeepak Kumar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.